Loading data
PGYNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.26 bn USD | 1 bn USD | 772.81 m USD | 685.41 m USD | 445.87 m USD |
| Cost of revenue | 749.17 m USD | 597.65 m USD | 508.94 m USD | 451.08 m USD | 232.32 m USD |
| Research and development expense | 75.21 m USD | 76.57 m USD | 74.38 m USD | 150.93 m USD | 66.21 m USD |
| Operating profit | 263.83 m USD | 66.84 m USD | -24.4 m USD | -251.51 m USD | -5.81 m USD |
| Profit before tax | 51.63 m USD | -421.12 m USD | -181.17 m USD | -276.37 m USD | -61.65 m USD |
| Income tax expense | -19.75 m USD | 24.58 m USD | 15.57 m USD | 16.4 m USD | 7.88 m USD |
| Net income (reported basis) | 81.39 m USD | -401.41 m USD | -128.44 m USD | -302.32 m USD | -91.15 m USD |
| Net income attributable to common shareholders | 77.28 m USD | -401.41 m USD | -128.44 m USD | -314.53 m USD | -134.32 m USD |
| Basic earnings per share | 0.99 USD/share | -5.66 USD/share | -2.14 USD/share | -8.22 USD/share | -8.25 USD/share |
| Diluted earnings per share | 0.93 USD/share | -5.66 USD/share | -2.14 USD/share | -8.22 USD/share | -8.25 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.